Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05923060 · ClinicalTrials.gov registry record · Phase 2
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
A Phase 2 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT05923060 is a Phase 2 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 14 participants.
The verdict
NCT05923060, a Phase 2 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of the study is to test a new video device for actinic keratoses. The device takes images of your skin lesions during the treatment, to learn whether this device can predict how well the treatment is working.
Interventions
- DRUG Topical Aminolevulinate
- PROCEDURE Photodynamic therapy (PDT)
- PROCEDURE Red light illumination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-08-25 |
| Est. Completion | 2025-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05923060
The ClinicalTrials.gov registry entry for NCT05923060 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Topical Aminolevulinate is the first listed.
NCT05923060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05923060 about?
NCT05923060 is a clinical study titled "Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses". The purpose of the study is to test a new video device for actinic keratoses. The device takes images of your skin lesions during the treatment, to learn whether this device can predict how well the treatment is working.
What is the current status of trial NCT05923060?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2024-08-25. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT05923060?
The interventions under investigation include: Topical Aminolevulinate (DRUG), Photodynamic therapy (PDT) (PROCEDURE), Red light illumination (PROCEDURE).
Who is sponsoring clinical trial NCT05923060?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.